MaxLinear Inc. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? MaxLinear Inc. Common Stock trades at $96.78 (market cap $8.50B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 6.9× MaxLinear Inc. Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while MaxLinear Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MaxLinear Inc. Common Stock for 0 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| MXL | TAK | |
|---|---|---|
Market Cap | $8.50B | $58.74B |
Volume | 4,008,439 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $128.03 | $19.05 |
52-Week Low | $13.05 | $13.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.58B | $86.65B |
Dividend Yield | — | 3.33% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →